PEGFILGRASTIM

UNII:	3A58010674
Formula:
Preferred Substance Name:	PEGFILGRASTIM

208265-92-3
B12019
B-12019
CEGFILA
CEGFILA [EMA EPAR]
CHS-1701
FULPHILA
FYLNETRA
GRANULOCYTE COLONY-STIMULATING FACTOR PEGFILGRASTIM
GRANULOCYTE COLONY-STIMULATING FACTOR PEGFILGRASTIM [MI]
HSP-130
LA EP 2006
LA EP-2006
LA-EP2006
LUPIFIL-P
MSB11455
MSB-11455
MYL-1401H
N-(3-HYDROXYPROPYL)METHIONYLCOLONY-STIMULATING FACTOR (HUMAN), 1-ETHER WITH .ALPHA.-METHYL-.OMEGA.-HYDROXYPOLY(OXYETHYLENE)
NEULASTA
NEUPOPEG
NYVEPRIA
PEG-FILGRASTIM
PEGFILGRASTIM (NEULASTA)
PEGFILGRASTIM [EMA EPAR]
PEGFILGRASTIM [INN]
PEGFILGRASTIM [JAN]
PEGFILGRASTIM [MART.]
PEGFILGRASTIM [PURPLE BOOK CDER]
PEGFILGRASTIM [USAN]
PEGFILGRASTIM [VANDF]
PEGFILGRASTIM [WHO-DD]
PEGFILGRASTIM APGF [WHO-DD]
PEGFILGRASTIM BIOSIMILAR (AMNEAL PHARMACEUTICALS)
PEGFILGRASTIM BIOSIMILAR (CHS-1701)
PEGFILGRASTIM BIOSIMILAR (COHERUS BIOSCIENCES)
PEGFILGRASTIM BIOSIMILAR (FRESENIUS KABI)
PEGFILGRASTIM BIOSIMILAR (HSP-130)
PEGFILGRASTIM BIOSIMILAR (KASHIV BIOSCIENCES)
PEGFILGRASTIM BIOSIMILAR (LA EP-2006)
PEGFILGRASTIM BIOSIMILAR (LUPIN)
PEGFILGRASTIM BIOSIMILAR (MUNDIPHARMA)
PEGFILGRASTIM BIOSIMILAR (MYL-1401H)
PEGFILGRASTIM BIOSIMILAR (MYLAN GMBH)
PEGFILGRASTIM BIOSIMILAR (PFIZER)
PEGFILGRASTIM BIOSIMILAR (QILI PHARMACEUTICALS)
PEGFILGRASTIM BIOSIMILAR (SANDOZ)
PEGFILGRASTIM BMEZ [WHO-DD]
PEGFILGRASTIM CBQV [WHO-DD]
PEGFILGRASTIM FOR BIOASSAY
PEGFILGRASTIM FOR BIOASSAY [USP-RS]
PEGFILGRASTIM JMDB [WHO-DD]
PEGFILGRASTIM PBBK [WHO-DD]
PEGFILGRASTIM, LICENSE HOLDER UNSPECIFIED
PEGFILGRASTIM-APGF
PEGFILGRASTIM-BMEZ
PEGFILGRASTIM-CBQV
PEGFILGRASTIM-CBQV [PURPLE BOOK CDER]
PEGFILGRASTIM-FPGK
PEGFILGRASTIM-JMDB
PEGFILGRASTIM-JMDB [PURPLE BOOK CDER]
PEGFILGRASTIM-LJFD
PEGFILGRASTIM-PBBK
PEGYLATED GRANULOCYTE COLONY STIMULATING FACTOR
PEGYLATED GRANULOCYTE COLONY STIMULATING FACTOR [WHO-DD]
PELMEG
PF-06881894
QL0605
QL-0605
STIMUFEND
STIMUFEND [EMA EPAR]
TPI-120
UDENYCA
ZIEXTENZO

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

PEGFILGRASTIM

Synonyms and Mappings

Resources